 Pharmacologic roles heparin glucocorticoids restenosis coronary angioplasty Restenosis successful percutaneous transluminal coronary angioplasty major clinical problem long-term efficacy treatment coronary atherosclerosis Recent advances understanding biology restenosis intimal hyperplasia smooth muscle cells predominant cause restenosis therapeutic agents vascular smooth muscle cell proliferation candidate drugs restenosis Heparin antiproliferative effects smooth muscle cells availability low molecular weight heparins anticoagulant properties ideal agents Glucocorticoids wide effects inflammatory wound healing events smooth muscle cell growth culture animal models arterial injury Recent laboratory data combination therapy low molecular weight heparin hydrocortisone powerful treatment regimen restenosis